The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer.
about
Recent advances of highly selective CDK4/6 inhibitors in breast cancerStrategies and Progress of Endocrine Therapy for Patients with Metastatic Breast Cancer.Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.Recent Advances in the Treatment of Breast Cancer.A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitorsCyclin-dependent kinase 4 is a preclinical target for diet-induced obesity
P2860
The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Growing Role of CDK4/6 Inh ...... sitive Advanced Breast Cancer.
@en
type
label
The Growing Role of CDK4/6 Inh ...... sitive Advanced Breast Cancer.
@en
prefLabel
The Growing Role of CDK4/6 Inh ...... sitive Advanced Breast Cancer.
@en
P2860
P1476
The Growing Role of CDK4/6 Inh ...... sitive Advanced Breast Cancer.
@en
P2093
Ami N Shah
Massimo Cristofanilli
P2860
P2888
P356
10.1007/S11864-017-0443-7
P577
2017-01-01T00:00:00Z
P6179
1083821533